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1. Introduction 
HIV or Human Immunodeficiency Virus, a RNA virus. On exposure to this virus, it directly 
attacks certain human organs, such as the heart, brain and kidneys. It plays a very 
significant role in weakening the immune system of its host. The immune system forms the 
framework in protecting the body from attack by any foreign agent like the bacteria, fungus, 
virus or any type of infection and even from some cancers by reacting accordingly. The 
primary cells attacked by HIV are the CD4+ lymphocytes, which are glycoprotein expressed 
on the surface of Th cells, macrophages, monocytes, regulatory T cells and dendritic cells 
and plays a vital role in performing important immune responses in the body. It helps in 
direct immune function in the body. It is via this CD4 that HIV-1 enters into the host T-cells. 
A progressive reduction in the number of T cells expressing CD4 occurs on HIV infection. 
Since CD4+ plays a very important role in maintaining a proper immune system function, 
progressive loss of CD4+ lymphocytes as destroyed by HIV, the immune system barely 
works. With more active HIV infection or on prolonged exposure to HIV would deprive the 
host of its CD4 containing cells and this reduced CD4 count leading to reduced host 
immunity. Opportunistic infections take advantage of this weak host immune system and 
manifest their adverse effects. Many people especially during the advanced stage of HIV 
infection face problems resulting from opportunistic infections (OIs) and cancers. 
The HIV/AIDS is a global epidemic and approximately 40 million people are living with 
HIV/AIDS worldwide (Quinn, 1996). Of all HIV/AIDS infected people, 95% are living in 
developing countries. Africa is the worst affected of all the continents. It consists of 19 
countries worldwide with the highest prevalence of reported infections with more than 24.5 
million, and more than 60% of the HIV-infected population. South Africa holds the record of 
being the country with the largest population living with the disease, at well over 5 million 
people infected. South Africa is followed by followed by Nigeria in 2nd place and India 
being the 3rd largest population of HIV infected people. Currently India about 5.134 million 
HIV infected cases are present in India which comprises of 65% cases of Southeast Asia. In 
India, HIV/ AIDS pandemic no longer belongs to the high-risk groups but now it is 
common among the general population (Ran & Hemalatha, 2006; Solomon et al.2006). 
Exponential growth of this epidemic is now at the threshold for India. 
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2. OIs associated with HIV  
As mentioned earlier, taking advantage of this weakened immune system of its host with 
advanced HIV infection several infections and malignancies called 'opportunistic 
infections' appear.Opportunistic Infections (OIs) have been recognized as common 
complications of HIV infection due to immune deficiency which detoriates both the 
standard of life and life expectancy of the these HIV infected people. One of the main 
reasons behind hospitalization and substantial morbidity in HIV infected patients due to 
these OIs. OIs have been recognized as common complications of HIV infection since the 
beginning of the HIV epidemic (Kanabus et al. 2006; CDC, 1982; Selik et al.1984). These OIs 
develop several complicacies which lead to substantial morbidity and hospitalization. 
Several toxic and expensive therapies are required as a part of the treatment procedure. 
These ultimately lead to shorten the survival of people with HIV infection OI (Moore & 
Chassion, 1996; Finkelstein et al.1996). The decrease in the CD4 count in these HIV 
infected people is not doubt partially responsible for these various OIs (Talib et al.1993). A 
dramatic reduction in the incidence of OI among HIV-positive people who have received 
ART has been observed on introduction of antiretroviral therapy (ART); however, 
HIV/AIDS patients all around the world cannot afford or are not exposed to ART. 
Millions of people living with HIV in resource-poor communities/ countries donot get 
access to ART and in these cases especially the occurrence of OIs is very common 
(Kanabus et al. 2006). Even where ART drugs are available, they do not entirely remove 
the need for preventing and treating OI. Because of poor adherence, drug resistance or 
other factors measures to prevent and treat OIs become essential if ART stops working. 
However, providing prevention and treatment of OIs is of utmost importance to these 
people as it not only helps HIV-positive persons to live longer, healthier lives, but it can 
also help to prevent tuberculosis (TB) and other transmissible OIs from spreading to 
others. At present, the absolute CD4+ count determines the initiation of primary 
prophylactic therapies for OIs, which is an excellent predictor of the short-term overall 
risk of developing AIDS among HIV-infected patients (Stein et al.1992). 
The spectrum and frequency of certain OIs highlight the urgency of studying HIV/AIDS in 
resource-limited countries like India where locally specific disease patterns may be 
observed. With the identification of such opportunistic pathogens in these HIV/AIDS 
patients, the HIV epidemic can be more effectively managed if physicians and health 
planners are aware of this information. The data may thus serve as a baseline, which can be 
implemented to the remote district level study as well and may further give an insight into 
the HIV related opportunistic infections would render help for subsequent HIV/AIDS care 
and management in a developing country like India.  
2.1 Study carried out by our research group  
In our study (published as Current Trends of Opportunistic Infections among HIV- Seropositive 
patients from Eastern India published in Jpn.J.Infect.Dis. 61, 49-53, 2008) the HIV-Co 
Opportunsitic infections from the cases reported from the various HIV-infected patients 
admitted Calcutta Medical College Hospital, Kolkata West Bengal, and of referred patients 
from Apex Clinic, Calcutta Medical College Hospital, a referral center for patients of HIV 
infection or AIDS were included. The patients admitted in the hospital were from different 
states of eastern India such as Bihar, Orissa, Jharkhand and from West Bengal. Their HIV 
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status was confirmed by three ERS (Enzyme-linked immunosorbent assay [ELISA], Rapid, 
Simple), an ELISA (viz., HIV ELISA, Rapid test) and Western blot as recommended by the 
National AIDS Control Organization (NACO), Ministry of Health and Family Welfare, 
Government of India (NACO,2000).  
For the diagnosis of OIs, routine microbiology smears, cultures and serology should be 
performed with utmost precaution. Different samples as directed by clinicians were 
collected depending on patient symptoms and clinical presentation under universal aseptic 
precautions in suitable sterile containers for the routine diagnosis. For the isolation, culture 
and identification of species of the pathogen in order to detect the OIs from blood samples, 
sputum and stool. OIs were diagnosed according to the criteria suggested by the Centers for 
Disease Control and Prevention (CDC) (CDC,1992). For isolation of Candida causing oral 
candidiasis to the HIV patients, Sabourand’s dextrose agar (SDA) was used as transporting 
media. Pseudohyphae and budding yeast were characteristic findings. The appearance of 
the lesion and presence of yeast forms on microscopic examination of the oropharynix were 
sufficient evidence to confirm the diagnosis (Kolmer et al.1969). The most prevalent and 
obtained pure culture of yeast was compared with referral strain Saccharomyces cerevisiae 
ATCC 2601 and that of Candida albicans spp. was compared with referral strain C. albicans 
ATCC 10231. Cases of TB were classified as definite if the culture for Mycobacterium 
tuberculosis was positive for acid-fast bacilli. The decontaminated sputum sample from the 
diagnosed TB patients was further studied for obtaining a pure culture of M. tuberculosis 
growing on prepared LJ slants.The positive pure cultures grew yellow colonies on the 
slants. The isolated pure culture of M. tuberculosis spp. was compared with referral strain M. 
tuberculosis ATCC 25177. Stool specimens from all diarrhea patients (following WHO criteria 
of watery stool for at last 48 h prior to investigation) were processed (da Silva, & Pieniazek, 
2003) and examined microscopically for the presence of Cryptosporidium parvum, a zoonotic 
pathogen that causes chronic watery diarrhea. The staining technique used for staining of 
Cryptosporidium was modified Ziehl-Neelsen (AFB staining). Cryptosporidia and other 
coccidia stained pink-red. The isolated pure culture of Cryptosporidium spp. was compared 
with a referral strain Cryptosporidium (Microbiology QC slides, Himedia SL45-10; 
Himedia).Enteric bacterial flora from the stool samples of diarrhea patients were isolated 
using differential selective screening media such as UTI agar (urinary tract infection agar; 
Himedia) after documenting their clinical manifestations, including intestinal flu, 
inflammation-associated cramping, abdominal pain, nausea and vomiting. Different enteric 
pathogens that exhibit a particular colony color facilitate the identity of particular 
microorganisms such as Escherichia coli (pink-magenta), Proteus mirabilis (light green), 
Enterococcus fecalis (bluish green), Staphylococcus aureus (cream), Pseudomonas aureginosa 
(colorless) and C. albicans (pin point white). For isolation of Vibrio cholerae and other 
enteropathogenic Vibrio, TCBS agar (thiosulfate citrate bile salt sucrose; SRL, Mumbai, India) 
was used. Cryptococcal meningitis was confirmed by clinical symptoms and signs as well as 
the detection of cryptococcal capsular antigen (Cryptococcus antigen latex agglutination Test; 
Remel, Lenexa, Kans., USA). Toxoplasmic encephalitis was diagnosed in the presence of at 
least two of the following findings: a history of neurological symptoms, neurological signs 
at admission or suggestive computed tomography scan or magnetic resonance imaging of 
the brain (Luft, & Remington,1988, 1992). A response to anti-Toxoplasma (IgM) antibodies, 
which was detected by a serological ELISA commercial kit gives a satisfactory result.  
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Table 1. Patient Characteristic 
In our study, 125 HIV (HIV-1 subtype) patients with OI were studied, of whom, 105 
(84%) were male and 20 (16%) were female. The majority of patients (52%) were 31 - 40 
years old followed by 27, 19 and 1% for the age groups 21 - 30, ≥41 and ≤20 years old, 
respectively. Heterosexual mode of transmission was obtained to be the predominant 
mode of transmission of HIV accounting for 64% of cases, followed by other routes 
(Table 1).  
According to CD4 cell count/cu mm of blood ,the distribution of the study population 
was a maximum 36% of the population with 101-200 CD4+ cell count, followed by 23, 22 
and 17% of patients with ≥201, 51 - 100 and ≤50 CD4 cell count, respectively. A 
significant finding from an epidemiological point of view was the complete absence of 
Yeast, HBV and venereal disease in female subjects. The follow-up of the case studies 
revealed that 7 cases (5.6%) out of 125 HIV-infected patients expired during the later 
period of their treatment. Ten (8%) of the study patients were receiving ART. 
Dermatological reactions were found as drug-related complications in patients with 
HIV infection. The most serious disorder, Steven-Johnson syndrome (SJS), was found to 
occur in 5 (4%) HIV-infected patients after intake of a combination of rifampicin-
isoniazid after beginning treatment for recurrent Pulmonary TB occurring as an OI 
(Pitche et al. 2005).  
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2.1.1 Prevalence of different OIs  
Oral candidiasis (OC) emerged as the most frequent infection to be associated with HIV 
infection in patients across the total range of CD4+ as studied by us among the spectrum of 
OIs observed. OC infection was found to be prevalent among 88% of these patients. Oral 
yeast (Saccharomyces)-infection was found in 5.6% of patients. TB emerged as the second 
most prevalent infection amongst the population as studied by us, developing in 57% of 
subjects. The diagnosis of TB was definite for all the suspected patients. Both pulmonary 
(69.4%) and extra pulmonary (16.6%) types were found to be prevalent. Amongst the HIV 
positive patients extra pulmonary TB was found to be prevalent amongst patients with 
lower median CD4+ counts (46/μl blood). But amongst the HIV/AIDS patients pulmonary 
TB was found amongst the patients having median CD4+ of 105/μl blood -which are the 
most common location of the disease. 
HIV is driving the tuberculosis (TB) epidemic in many developing countries including India. 
During our study to determine the drug resistance pattern of pulmonary TB among HIV 
seropositive and HIV negative hospitalized patients from different states of Eastern India, 
(published as Drug susceptibility profile of Mycobacterium tuberculosis isolated from HIV infected 
and uninfected pulmonary tuberculosis patients in Eastern India in Transactions of the Royal 
Society of Tropical Medicine and Hygiene 104 (2010) 195–201) the TB positive isolates were 
screened and characterized by conventional laboratory methods followed by first- and 
second-line drug susceptibility testing on Lowenstein-Jensen medium by the proportion 
method. The drug susceptibility testing showed 17.7% and 6.6% multidrug-resistant (MDR) 
TB for the HIV positive and HIV negative patients, respectively. 22.2% of the isolated MDR-
TB cases could be classified as extensively drug-resistant (XDR) TB isolates. 88.8% of all the 
MDR-TB isolates and all XDR-TB isolates were screened from HIV patients. 27.7% of the 
MDR-TB isolates showed resistance to all the first-line drugs. Mortality rate among the 
XDR-TB isolates was as high as 75%. Patients with interrupted anti-TB drug treatment were 
the ones most affected. These findings are critical and the risk to public health is high, 
particularly with HIV infected patients. 
The pathogen most frequently isolated from the diarrheic patients was C. parvum (43.1%).   
In about 47% of the immunocompromised patients, various enteropathogenic species of 
Vibrio were found, while simultaneously the presence of bacterial pathogens from 
Enterobacteriacae was 40% and E. coli was found in 42% of cases. 
Among the viral OIs, CMV infection was the most predominant; 45% of subjects were 
positive for CMV infection among 125 HIV-seropositive study subjects. The other viral 
infections found in the study population were HSV (7.2%) and HBV (5.6%) which were 
much less in comparison to the prevalence of CMV infection. The absence of any specific 
clinical symptoms of CMV amongst the patients was an important characteristic of CMV 
infection and was often indistinguishable from other types of infection. The common 
unifying feature of CMV disease in the immunocompromised patient was the presence of 
fever, and approximately 65% of cases developed hearing defects and perceptual organ 
damage such as optic atrophy and blindness. 
The most common form of disseminated cryptococcosis was Meningitis, and it developed in 
4% of the study patients. All cases were diagnosed by clinical and neurological symptoms 
with confirmation by laboratory investigations. 
Very few other OIs were found, viz., herpes zoster virus (HZV) infection, syphilis from 
T.pallidum, etc., among the patients investigated. Interestingly, not even a single case of 
malignancy was found to occur among the investigated patients. 
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2.1.2 Highlights of our study 
Our study highlights that candidial infection is the most common OI, followed by TB and 
diarrhea, all of which are presumed to result from our geographic, climatic and socio-
economic conditions. Early diagnosis of OIs and prompt treatment definitely contributes to 
increased life expectancy among infected patients, delaying the progression to AIDS. 
Despite the moderate (n = 125) number of patients included in our study, we believe the 
data obtained here provide some important background information that can form the basis 
of future, more elaborative and systematic studies. Furthermore, the data shown can be a 
valuable means of determining the range and relative frequency of infectious diseases, and 
this can potentially have an immediate impact on patient care by suggesting appropriate 
interventions based on the results. 
The following table (2) represents the cases of dual infection in these HIV infected 
patients: 
 
Co-infection with Oral 
Candiditis 
Number of cases Percentage of Cases 
Enteropathogenic Vibrio 47 37.6 
Tuberculosis 50 40.0 
Escherichia coli infection 42 33.6 
Cryptosporidial diarrhea 40 32.0 
Table 2. Represents the cases of dual infection in these HIV infected patients 
As a part of our investigation, we also studied co-infection of Oral Candidiasis with other 
OIs among the different HIV/AIDS population:  
The figures below demonstrate: 
The Venn Diagrams below demonstrate the co-infections: 
 
 
 
Fig. 1. Co-infection of Oral candidiasis with Enteropathogenic Vibrio 
Oral candidiasis was found to be prevalent amongst 110 of the 125 HIV/AIDS infected 
patients. Enteropathogenic Vibrio was found to be prevalent amongst 54 of the AIDS/HIV 
infected patients. Amongst them, 40 developed co-infection of these two OIs. Thus, only 14 
of the 54 patients infected with Enteropathogenic Vibrio did not develop any infection from 
Oral candidiasis.  
From our study, it again becomes very prominent that HIV/AIDS patients suffering from 
Enteropathogenic Vibrio have high possibility of developing infection from Oral candidiasis. 
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Fig. 2. Co-infection of Oral candidiasis with E coli 
Oral candidiasis was found to be prevalent amongst 110 of the 125 HIV/AIDS infected 
patients as mentioned previously. E coli infection was found to be prevalent amongst 53 of 
the AIDS/HIV infected patients. Amongst them, 42 developed co-infection of these two OIs. 
Thus, only 11of the 53 patients infected with E coli did not develop any infection from Oral 
candidiasis.  
From our study, it again becomes very prominent that HIV/AIDS patients suffering from E 
Coli develop high possibility of developing infection from Oral candidiasis. 
 
 
 
Fig. 3. Co-infection of Oral candidiasis with E coli 
Oral candidiasis was found to be prevalent amongst 110 of the 125 HIV/AIDS infected 
patients as mentioned previously. TB infection was found to be prevalent amongst 68 of the 
AIDS/HIV infected patients. Amongst them, 50 developed co-infection of these two OIs. 
Thus, only 18of the 58 patients infected with TB did not develop any infection from Oral 
candidiasis.  
From our study, it again becomes very prominent that HIV/AIDS patients suffering from 
TB develop high possibility of developing infection from Oral candidiasis. 
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Oral candidiasis
Cryptosporidial diarrhea 
Oral candidiasis + Cryptosporidial diarrhea coinfection
 
 
Fig. 4. Co-infection of Oral candidiasis with Cryptosporal diahorrhea 
Oral candidiasis was found to be prevalent amongst 110 of the 125 HIV/AIDS infected 
patients as mentioned previously. Cryptosporal diahorrheal  infection was found to be 
prevalent amongst 59 of the AIDS/HIV infected patients. Amongst them, 47 developed co-
infection of these two OIs. Thus, only 12 of the 59 patients infected with TB did not develop 
any infection from Oral candidiasis.  
From our study, it again becomes very prominent that HIV/AIDS patients suffering from 
Cryptosporal diahorrhea develop high possibility of developing infection from Oral 
candidiasis. 
In another different study undertaken by our research group, (published as Incidence of 
multiple herpesvirus infection in HIV seropositive patients, a big concern for Eastern Indian scenario 
published in Virology Journal 2010, 7:147) we were also eager to study the spread of the 
different betaherpes virus infection amongst these HIV infected patients. All herpes viruses 
share a characteristic ability to remain latent within the body over long periods. These 
herpes viruses play a very important role in further worsening the scenario in case of the 
HIV infected patients. For this purpose, in order to investigate the incidence of the different 
herpes viruses amongst the HIV/AIDS patients, we reviewed 200 HIV/AIDS patients, 
admitted between January 2006 to November 2008 at Calcutta Medical College Hospital, 
Kolkata, West Bengal, Apex Clinic, Calcutta Medical College Hospital- and ART Center, 
School of Tropical Medicine, for the detection of viral opportunistic infections. Their HIV 
status was confirmed as before by three ERS (Enzyme Linked Immunosorbent Assay 
[ELISA], Rapid, Simple) as before, an ELISA (HIV ELISA, Rapid test)and Western Blot as 
recommended by the National Aids Control Organization (NACO), Ministry of Health and 
Family Welfare, Government of India. The admitted patients were referred to us because 
they presented symptoms related to HIV infection or symptoms of unknown origin such as 
prolonged fever. The study group comprised of 140 (70%) males and 60 (30%) females, with 
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mean ages of 36 ± 16 and 35 ± 12 years respectively. The patients included in the study were 
from different states of Eastern India.  
The viral OIs were primarily diagnosed by the common clinical manifestations as diagnosed 
by the clinicians.  
2.1.3 Primary clinical symptoms for CMV infection (As confirmed by the clinicians) 
For the diagnosis of active CMV infection, the primary clinical symptoms were retinitis (an 
infection of the eyes), pneumonia, blindness and gastrointestinal disease. The common 
clinical feature of CMV disease is retinitis. Retinitis is charecterised by painless, gradual loss 
of vision, floaters etc. Often, retinitis begins in one eye, but then progresses gradually to the 
other eye. If kept without treatment, progressive damage to the retina can lead to blindness 
in 4-6 months or less. Even with regular treatment, the disease can worsen to blindness. This 
may be because CMV may become resistant to the drugs so the drugs can no longer kill the 
virus, or because the patient's immune system has deteriorated further. Patients with CMV 
retinitis also have a chance of developing retinal detachment, in which the retina detaches 
from the nerves of the eye, causing blindness. 
Other symptoms following active CMV infection include oesophagitis. Cytomegalovirus 
(CMV) esophagitis is a viral infection of the esophagus, which is the muscular tube through 
which food travels from the mouth to the stomach. It is charecterised by dysphagia - 
difficulty in swallowing or Odynophagia - painful swallowing,low grade fever, mouth 
sores. 
Colitis is another clinical symptom due to active CMV infection. The clinical presentation ae 
as follows: pain abdomen, bloody diarrhea, fever, anorexia, malaise,dehydeation, weight 
loss, chronic watery diahorrea. HIV infected patients suffering from CMV colitis usually 
benefit from antiviral treatment.  
CMV Pneumonitis is charecterised by cough, breathlessness. Pneumonitis is a common 
manifestation of CMV infection. It is highily associated with immunocompromised patients 
with fever and dyspnea.  
Encephalitis caused by CMV is characterized by altered mental status, convulsion and 
headache. 
Radiculoneuropathy is characterized by weakness/paralysis of lower limbs, pain lower 
back, urinary retention etc.  
2.1.4 Primary clinical symptoms for HSV infection (As confirmed by the clinicians) 
Among HIV-1 infected individuals, HSV-1 and HSV-2 infections are common, with 
prevalences that approximate or exceed those in the general population. Primary symptoms 
of HSV included persistent vesicular and ulcerative lesions of the oral and anogenital areas, 
often with extensive or deep ulcerations and blisters on or around the genitals or rectum. 
The blisters left tender ulcers (sores) that took two to four weeks to heal the first time they 
occurred. Other symptoms included tender tonsils covered with a whitish substance that 
made swallowing difficult or blisters present in the mouth.  
2.1.5 Primary clinical symptoms for EBV infection 
EBV+ and HIVincreases by many fold the risk of non-Hodgkins lymphoma (NHL) over 
general population, though overall risk remains small. In HIV, EBV most highly 
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associated with Lymphoma, Primary CNS (PCNSL). Primary diagnosis of EBV was based 
on the clinical symptoms of fever, sore throat and swollen lymph glands. The 
commonestclinical presentation of EBV disease in HIV positives is Oral hairy Leukoplakia 
(OHL). 
2.1.6 Primary clinical symptoms for HSV infection 
Patients with HIV disease are at risk for developing severe illness from either varicella or 
zoster. Progressive primary varicella, a syndrome with persistent new lesion formation 
and visceral dissemination, may occur in HIV-infected patients and may be life-
threatening. Zoster eruptions in HIV-infected patients can be extensive and locally 
destructive, and can become secondarily infected. Zoster may also disseminate 
cutaneously, and has been reported as the cause of encephalitis in patients with HIV 
disease (Quinnan et al. 1984; 
Cone  &  Schiffman, 1984 ;Sandor et al. 1984 ;Ryder et al.1986; Friedman-Kien  et al.1986;  
Cohen  et al.1988; Colebunders  et al.1988; Cohen, & Grossman,  1989 ; Gilson et al. 1989;  
Eidelberg et al.1986) was primarily diagnosed based on the clinical manifestations of severe 
headaches, backache, general malaise and fever accompanied by the typical exanthem (rash) 
of chickenpox. Other symptoms of VZV included painful oral lesions, vesicular rash, facial 
numbness and loss of hearing/ ear pain.  
All the clinical manifestations were confirmed by ELISA test. The following diagnostic test 
kits were used for the assay of the opportunistic viruses: 
Anti- CMV 
Serum anti-CMV was determined by a commercially available test kit, CMV IgM, IgG 
ELISA Test kit was used to detect antibodies against the CMV. 
Anti - EBV 1 
Serum anti-EBV was determined by a commercially available test kit, EBV IgG, IgM ELISA 
Test kit was used to detect antibodies against the EBV 1. 
Anti- HSV 2 
Serum anti- HSVwas determined by a commercially available test kit, HSV type1 IgM ELISA 
Test kit supplied was used to detect antibodies against the affinity chromatographically 
purified recombinant antigen HSV-2. 
Anti - VZV 
Serum anti-VZV was determined by a commercially available test kit, VZV IgM, IgG, IgA  
Was used to detect antibodies against the Ellen Strain antigen (ATCC). 
Of these herpes viruses studied, our study within the studied population suggests that, the 
occurrence of CMV is the highest. It accounts to 49% of the total population studied across 
the range of CD4+.  
From the different tests performed, the results were as follows: 
The following table (3) represents the cases of viral OIs in these HIV infected patients: 
Study population= 200 
We were also interested to study the trend of co-infection with CMV amongst these HIV 
patients.  
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Type of Viral infection No. of positive cases %  
CMV  98 49  
HSV  94 47  
VZV  52 26  
EBV  65 32.5  
Table 3. Represents the cases of viral OIs in these HIV infected patients. 
CMV was found to be associated predominantly with HSV followed by EBV and VZV. 
Presence of CMV associated viral OIs in HIV infected population 
The following table (4) represents the cases of dual infection with CMV in these HIV 
infected patients: 
Study population= 200 
 
Viral Co-infections No. of positive cases %  
CMV+HSV  71 35.5  
CMV+VZV  32 16  
CMV+EBV  41 20.5  
Table 4. Represents the cases of dual infection with CMV in these HIV infected patient 
The Venn diagrams below to demonstrate the actual distribution of these viral infections 
amongst the immunocompromised patients under our study: 
 
 
 
Fig. 5. Co-infection of CMV with HSV 
CMV was found to be prevalent amongst 98 of the 200 HIV/AIDS infected patients as 
mentioned previously. HSV infection was found to be prevalent amongst 94 of the 
AIDS/HIV infected patients. Amongst them, 71 developed co-infection of these two OIs.  
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Fig. 6. Co-infection of CMV with EBV 
CMV was found to be prevalent amongst 98 of the 200 HIV/AIDS infected patients as 
mentioned previously. HSV infection was found to be prevalent amongst 65 of the 
AIDS/HIV infected patients. Amongst them, 41 developed co-infection of these two OIs.  
 
 
Fig. 7. Co-infection of CMV with EBV 
CMV was found to be prevalent amongst 98 of the 200 HIV/AIDS infected patients as 
mentioned previously. VZV infection was found to be prevalent amongst 52 of the 
AIDS/HIV infected patients. Amongst them, 45 developed co-infection of these two OIs.  
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The incidence of CMV was higher among males than females 59/39. HSV was also found to 
be more predominant in the males 63/ 31. The incidence of VZV and EBV was also found to 
be dominant in the male population, the dominancy being 46/19 and 31/21 respectively. 
HSV infection is found to be dominating in the heterosexual individuals among the study 
group. There are no significant variations among the homophiles, the drug users and the 
blood transfusion patients.The incidence of the different viral OIs was also assessed with 
respect to the CD4+ cell count/μl of blood and patients with mean CD4+ cell count of 51-100 
showed the highest prevalence of opportunistic viral antibodies. This was followed by the 
group with CD4+ count of 101-150, 51-100, 151-200 and >200.  
Age related prevalence of opportunistic viral antibodies in the serum of 200 HIV infected 
patient cohorts was assessed and results showed that individuals in the age group of 21- 40 
years had the highest incidence of viral opportunistic infections as evident from the Table 
below. 
The following table (5) represents the HIV-seropositive patient groups in various risk 
factors: 
 
 
Table 5. Represents the HIV-seropositive patient groups in various risk factors. 
Viral opportunistic infections and HIV/AIDS having become so intertwined have 
constituted a major public health problem in the country. The opportunistic infections, 
Therefore, play a major role in clinical presentations and remain one of the most frequent 
causes of death in these patients. The Table below shows the association of the different OIs 
with the different modes of transmission of HIV amongst the different sexes amongst 
patients suffering from HIV/AIDS.  
The following table (6) represents the different opportunistic viruses which infects 
HIV/AIDS patients of different age groups 
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Table 6. Represents the different opportunistic viruses which infects HIV/AIDS patients of 
different age groups 
From our study, as mentioned previously, CMV was obtained as the most prevalent 
amongst the different viral OIs amongst the patients suffering from HIV/AIDS. Infection by 
cytomegalovirus (CMV) is the major cause of morbidity and mortality in individuals with 
depressed cell mediated immunity of congenital origin, iatrogenic origin and that associated 
with acquired immunodeficiency syndrome (AIDS). The clinical diagnosis of AIDS with 
CMV infection can be difficult in the absence of CMV retinitis, polyradiculopathy and the 
classical CMV syndrome (Wiley & Nelson ,1988; Santosh et al.1998). The diagnosis poses 
difficulties because a 2-3 week period is mandatory for virus isolation. While IgM antibodies 
as detected by ELISA correlate poorly with the clinical status of CMV infection and facilities 
for culture are usually not available in most centers (Lanjewar et al. 1996). There are a few 
reports available of CMV infection in Indian patients with HIV/AIDS, which are based 
primarily on clinical or autopsy evaluation (Lanjewar et al. 1988; Becker et al. 1996; 
Nebuloni et al. 1998). We found CMV as the most incidental co infection in HIV/ AIDS 
patient with the overall incidence of 49%. Human immunodeficiency virus (HIV) infection is 
associated with an increased risk for human herpesviruses (HHVs) and their related 
diseases. The incidence of HSV in human immunodeficiency virus (HIV)-seropositive 
patients has not been focused, with reports generally focusing on individual infection 
(Mcclain et al. 1995). In this report, the serum prevalence of HSV is found to be higher in 
HIV seropositive patients; the overall incidence is around 47%. VZV infection, the overall 
incidence being 32.5% is the third most incidental coinfection in HIV seropositive patients. 
VZV is one of the common aetiological agents of viral retinitis. Neurological complications 
of the reactivation of VZV occur most frequently in elderly persons and 
immunocompromised patients (Sixbey et al. 1989). Gray et al.(1994) reported VZV infection 
of the CNS in more than 4% of patients with AIDS examined at autopsy. In AIDS patients, 
VZV tends to reactivate from multiple dorsal root ganglia levels, and the disease is often 
disseminated. 
EBV is the least prevalent among the four HHVs studied in our work which is 26% of the 
total. EBV has been identified as a co-factor in the pathogenesis of a significant proportion of 
HIV related lymphoproliferative disorders and in oral hairy leukoplakia (Sculley et al. 1988). 
However, only limited information exists on the status of EBV in the course of HIV infection 
and the extent of its interaction with HIV. There is also growing interest in the biological 
properties and pathogenic potential of the different EBV subtypes, EBV-1 and EBV-2. 
Serological findings and studies in saliva and blood have indicated a high incidence of EBV-
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2 infection in the course of HIV disease, but there is limited information regarding its 
significance (Sixbey et al. 1989; Sculley et al. 1988). 
The analysis of the association of immunological status and the presence of viral OIs 
revealed that the CD4 count was significantly associated with the presence of viral OIs. An 
increasing CD4 count significantly protected patients from expressing HHVs in our patient 
cohorts as indicated by the correlation as in Figure 2. It has been detected clinically that 
more frequently virus infections are associated with the compromised immunity in 
HIVinfected patients (Kyaw et al.1992). We found that, HIV-infected patients with CD4+ cell 
counts of around 200 cells/mm3 are less likely to be infected with any virus examined here 
suggesting that a higherCD4+ cell count does play a role in immunity against virus 
infection. This clinical outcome is consistent with our finding of significantly lower CD4 cell 
count in HIV patients with viral OIs, indicating that the diagnosis of viral opportunistic  
 
 
Fig. 7. CD4+ counts/μL of blood versus the antibody titres against the different 
opportunistic viruses in the patients. The CD4+ count ranges between 50/μL to 300/μL and 
the antibody titres showing the mean OD of the triplicate ELISA reading. 
 
 
Fig. 8. Antibody prevalence of the corresponding viruses in different age groups of our 
patients samples. 
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infections can indeed be correlated with the clinical manifestation and thus is helpful in 
predicting disease progression. Figure 3 clearly shows that the patient group with CD4+ 
counts between 51 and 100 cells/μl is most susceptible to viral OI in HIV/AIDS patient. 
The groups with CD4+ count less than 50 cells/μl are showing least opportunistic viruses 
which could be due to the advanced HAART treatment. This study is aimed at providing 
baseline data on viral opportunistic infections in HIV seropositive population as part of the 
preliminary investigation on the dynamics of viral opportunistic infections in 
immunocompromised population of India. One of the major problems is the lack of specific 
investigations that can provide rapid and reliable confirmation of a clinical diagnosis. A 
high level of alertness is needed at both clinical and laboratory level and routine 
surveillance studies need to be undertaken. Institutions in India and other developing 
countries need to be equipped to face the emerging challenge, in the form of updating the 
present knowledge, by way of education and training of the personnel, acquisition of skills 
of improved procedures, and their implementation in appropriate settings with adequate 
administrative support. 
3. Conclusion 
This study is aimed at providing baseline data for different pathogenic opportunistic 
infections in HIV seropositive population as part of the preliminary investigation on the 
dynamics of viral opportunistic infections in immunocompromised population of Eastern 
India. As many HIV/AIDS patients in India cannot afford ART, so the detection and 
awareness towards OIs related to HIV is of immense importance especially in Indian 
perspective or with respect to other developing countries also. These data may also be of 
immense importance especially to those countries of the tropical region as the spread of OIs 
might be comparable to that of our study. A high level of alertness is needed at both 
laboratory and clinical level and routine surveillance studies need to be undertaken. 
Institutions in India and other developing countries need to be equipped to face the 
emerging challenge, in the form of updating the present knowledge, by way of education 
and training of the personnel, acquisition of skills of improved procedures, and their 
implementation in appropriate settings with adequate administrative support. Further 
investigations have to be undertaken with matched control samples as case control analysis 
with respect to all OIs in HIV seropositive individuals. 
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